Jiangzhong Pharmaceutical Co Ltd Asset Resilience Ratio
Jiangzhong Pharmaceutical Co Ltd asset resilience ratio. Jiangzhong Pharmaceutical Co Ltd (600750) has an Asset Resilience Ratio of 3.67% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See defensive interval ratio of Jiangzhong Pharmaceutical Co Ltd to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Jiangzhong Pharmaceutical Co Ltd (1997–2025)
Asset resilience ratio of Jiangzhong Pharmaceutical Co Ltd from 1997 to 2025. This chart shows how Jiangzhong Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Read 600750 total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Jiangzhong Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Jiangzhong Pharmaceutical Co Ltd's balance sheet.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥247.27 Million | 3.67% |
| Total Liquid Assets | CN¥247.27 Million | 3.67% |
Asset Resilience Insights
- Limited Liquidity: Jiangzhong Pharmaceutical Co Ltd maintains only 3.67% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Jiangzhong Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Jiangzhong Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Ajanta Pharma Limited
NSE:AJANTPHARM |
Drug Manufacturers - Specialty & Generic | 14.99% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262 |
Drug Manufacturers - Specialty & Generic | 26.45% |
|
Porton Fine Chemicals Ltd
SHE:300363 |
Drug Manufacturers - Specialty & Generic | 6.85% |
|
Jubilant Pharmova Limited
NSE:JUBLPHARMA |
Drug Manufacturers - Specialty & Generic | 1.26% |
Jiangzhong Pharmaceutical Co Ltd Asset Resilience Ratio by Year (1997–2025)
Jiangzhong Pharmaceutical Co Ltd asset resilience ratio by year from 1997 to 2025. The table below shows the annual Asset Resilience Ratio data for Jiangzhong Pharmaceutical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 1.38% | CN¥95.10 Million ≈ $13.92 Million |
CN¥6.88 Billion ≈ $1.01 Billion |
+1.23pp |
| 2024-12-31 | 0.15% | CN¥10.01 Million ≈ $1.46 Million |
CN¥6.51 Billion ≈ $952.32 Million |
-0.63pp |
| 2023-12-31 | 0.78% | CN¥50.02 Million ≈ $7.32 Million |
CN¥6.40 Billion ≈ $936.73 Million |
-21.09pp |
| 2022-12-31 | 21.87% | CN¥1.37 Billion ≈ $200.89 Million |
CN¥6.28 Billion ≈ $918.41 Million |
-6.93pp |
| 2021-12-31 | 28.81% | CN¥1.73 Billion ≈ $252.82 Million |
CN¥6.00 Billion ≈ $877.64 Million |
+8.88pp |
| 2020-12-31 | 19.92% | CN¥980.89 Million ≈ $143.54 Million |
CN¥4.92 Billion ≈ $720.47 Million |
+6.18pp |
| 2019-12-31 | 13.74% | CN¥654.07 Million ≈ $95.71 Million |
CN¥4.76 Billion ≈ $696.42 Million |
-9.83pp |
| 2018-12-31 | 23.58% | CN¥899.96 Million ≈ $131.69 Million |
CN¥3.82 Billion ≈ $558.54 Million |
+23.50pp |
| 2003-12-31 | 0.08% | CN¥800.00K ≈ $117.07K |
CN¥986.94 Million ≈ $144.42 Million |
-1.33pp |
| 2000-12-31 | 1.41% | CN¥10.00 Million ≈ $1.46 Million |
CN¥708.47 Million ≈ $103.67 Million |
-1.01pp |
| 1997-12-31 | 2.42% | CN¥9.98 Million ≈ $1.46 Million |
CN¥412.00 Million ≈ $60.29 Million |
-- |
About Jiangzhong Pharmaceutical Co Ltd
China Resources Jiangzhong Pharmaceutical Co.,Ltd engages in the manufacture of pharmaceutical products in China. The company offers OTC products, including stomach-strengthening and digestion-promoting tablets, lactobacillus tablets, triple live bifidobacterium enteric-coated capsules, compound fresh bamboo juice liquid, compound coral lozenges, multivitamin tablets, fritillaria and loquat capsu… Read more